While reporting financial results for the fourth quarter on Monday, biotechnology company Revvity, Inc. (RVTY) initiated its adjusted earnings and total revenue guidance for the full-year 2026.
For fiscal 2026, the company now projects adjusted earnings in a range of $5.35 to $5.45 per share on total revenues between $2.96 billion and $2.99 billion.
On average, analysts polled expect the company to report earnings of $5.32 per share on revenues of $2.94 billion for the year. Analysts' estimates typically exclude special items.
In Monday's pre-market trading, RVTY is trading on the NYSE at $109.94, up $1.14 or 1.05 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.